Compass Therapeutics Balance Sheet (2022-2026) | CMPX

Balance Sheet Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 34.90M27.03M19.28M30.43M24.23M43.48M19.40M19.40M44.05M41.62M23.42M46.21M31.21M55.17M
Short-term Investments (Quarter) 151.66M148.14M149.47M133.28M128.23M132.58M126.82M98.60M83.24M71.59M78.09M173.68M178.26M139.52M
Cash & Current Investments (Quarter) 186.56M175.17M168.75M163.70M152.46M176.06M146.23M118.00M127.29M113.20M101.52M219.90M209.47M194.69M
Prepaid Assets (Quarter) 8.18M8.43M6.52M2.88M1.42M2.36M7.32M5.74M6.03M11.51M5.25M1.23M0.91M1.00M
Current Assets (Quarter) 194.79M183.60M175.27M166.58M153.88M158.61M153.55M141.14M132.75M124.14M106.19M221.12M209.82M195.69M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.57M1.37M1.20M1.05M0.90M0.74M0.59M0.49M0.35M0.10M0.13M0.12M0.10M0.17M
Other Non-Current Assets (Quarter) 0.32M0.32M0.32M0.32M0.32M0.32M0.32M0.57M0.57M0.57M0.57M0.57M0.57M0.57M
Non-Current Assets (Quarter) 4.85M4.37M3.91M3.45M2.99M2.53M2.06M8.01M7.65M7.31M10.50M10.14M9.77M9.48M
Assets (Quarter) 199.65M187.97M179.18M170.04M156.88M161.14M155.61M149.15M140.40M131.45M116.70M231.26M219.59M205.17M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 3.38M1.12M0.72M2.31M4.09M0.85M1.19M0.96M2.25M1.58M2.60M3.10M1.58M0.91M
Payables (Quarter) 3.38M1.12M0.72M2.31M4.09M0.85M1.19M0.96M2.25M1.58M2.60M3.10M1.58M0.91M
Accumulated Expenses (Quarter) 11.69M0.53M7.83M5.64M1.94M0.79M2.31M2.69M2.79M1.49M2.00M2.48M11.38M1.19M
Other Accumulated Expenses (Quarter) 0.10M0.14M0.26M0.39M0.24M0.28M0.31M0.17M0.62M0.27M0.38M0.14M0.48M0.71M
Current Leases (Quarter) 1.10M1.12M1.15M1.17M1.20M1.22M1.09M0.56M0.34M0.11M0.27M1.00M1.00M1.37M
Total Current Liabilities (Quarter) 16.17M11.19M9.70M9.12M7.80M3.89M9.51M4.43M8.87M14.90M13.86M12.41M13.97M10.28M
Non-Current Liabilities
Operating Leases (Quarter) 1.84M2.64M1.20M0.87M0.54M0.19M1.09M6.88M6.30M6.38M9.63M9.83M8.83M9.79M
Total Liabilities (Quarter) 18.01M12.71M10.89M9.99M8.34M4.08M9.51M10.75M15.17M21.17M23.49M21.65M22.80M18.70M
Shareholder's Equity
Common Equity (Quarter) 181.64M175.26M168.29M160.04M148.54M157.06M146.10M138.40M125.23M110.28M93.21M209.61M196.79M186.47M
Shareholder's Equity (Quarter) 181.64M175.26M168.29M160.04M148.54M157.06M146.10M138.40M125.23M110.28M93.21M209.61M196.79M186.47M
Liabilities and Shareholders Equity (Quarter) 199.65M187.97M179.18M170.04M156.88M161.14M155.61M149.15M140.40M131.45M116.70M231.26M219.59M205.17M
Retained Earnings (Quarter) -272.81M-0.15M-291.93M-0.43M-315.31M-0.09M-0.09M0.49M0.21M0.19M-401.20M-415.46M0.28M-449.49M
Treasury Shares (Quarter) 0.90M1.80M1.80M1.80M1.50M3.67M3.67M3.67M3.77M2.94M2.94M1.28M1.03M1.61M